MedTrace Logo

Use of Nitazoxanide and Probiotics in Acute Diarrhea Secondary to Rotavirus

NCT00683982 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2008-05-26

No results posted yet for this study

Summary

Nitazoxanide has proved an cytoprotective effect against rotavirus infection. How it could be clinically important in time of hospitalization and reduction of duration of diarrhea secondary to rotavirus?

Conditions

Interventions

DRUG

Nitazoxanide

Nitazoxanide 15mg/Kg/day twice day for 3 days

DRUG

Probiotic mix preparation

Probiotic preparation 1 gram twice a day for 5 days

OTHER

Oral hydration solutions

Oral hydration solutions as needed

Sponsors & Collaborators

  • Centro Pediatrico Albina de Patino

    lead OTHER

Principal Investigators

  • Carlos N Teran, M.D · Centro Pediatrico Albina Patiño

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
28 Days
Max Age
24 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2008-05-31
Completion
2008-05-31

Countries

  • Bolivia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00683982 on ClinicalTrials.gov